Guild Associates, Inc. (DBA Guild BioSciences)

Guild BioSciences (GBS) is a specialized bioscience research and development division of Guild Associates, Inc., a company with over three decades of experience in chemical defense, military systems, and industrial technologies. GBS focuses on the creation and commercialization of innovative biological solutions, including the proprietary ImmobiZyme enzyme immobilization technology and advanced biosensors. The division leverages its multidisciplinary engineering and production support from its parent organization to transition research into practical applications. Its facilities in Dublin, Ohio, and Charleston, South Carolina, are equipped with BioSafety Level 2 laboratories and pilot-scale fermentation capabilities, allowing the team to manage projects from initial research through to manufacturing.

Serving diverse sectors including military, health, food, and environmental markets, Guild BioSciences provides expertise in pathogen detection and refined bioprocessing. The division has successfully demonstrated its reporter phage technology, such as LumiPhage, for the rapid detection of bioterrorism agents like anthrax and plague in various sample types. By operating as an agile business unit, GBS engages in government-funded programs, corporate partnerships, and internal product development. Its commitment to research integrity and business viability is supported by a portfolio of international patents and a collaborative team of scientists dedicated to solving complex technical challenges.